Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock
Open Access
- 2 December 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0278708
Abstract
Introduction: The search for new biomarkers that allow an early diagnosis in sepsis and predict its evolution has become a necessity in medicine. The objective of this study is to identify, through omics techniques, potential protein biomarkers that are expressed in patients with sepsis and their relationship with organ dysfunction and mortality.Methods: Prospective, observational and single-center study that included adult patients (≥ 18 years) who were admitted to a tertiary hospital and who met the criteria for sepsis. A mass spectrometry-based approach was used to analyze the plasma proteins in the enrolled subjects. Subsequently, using recursive feature elimination classification and cross-validation with a vector classifier, an association of these proteins with mortality and organ dysfunction was established. The protein-protein interaction network was analyzed with String software.Results: 141 patients were enrolled in this study. Mass spectrometry identified 177 proteins. Of all of them, and by recursive feature elimination, nine proteins (GPX3, APOB, ORM1, SERPINF1, LYZ, C8A, CD14, APOC3 and C1QC) were associated with organ dysfunction (SOFA > 6) with an accuracy of 0.82 ± 0.06, precision of 0.85 ± 0.093, sensitivity 0.81 ± 0.10, specificity 0.84 ± 0.10 and AUC 0.82 ± 0.06. Twenty-two proteins (CLU, LUM, APOL1, SAA1, CLEBC3B, C8A, ITIH4, KNG1, AGT, C7, SAA2, APOH, HRG, AFM, APOE, APOC1, C1S, SERPINC1, IGFALS, KLKB1, CFB and BTD) were associated with mortality with an accuracy of 0.86 ± 0.05, a precision of 0.91 ± 0.05, a sensitivity of 0.91 ± 0.05, a specificity of 0.72 ± 0.17, and an area under the curve (AUC) of 0.81 ± 0.08 with a confidence interval of 95%.Conclusion: In sepsis there are proteomic patterns associated with organ dysfunction and mortality.Keywords
Funding Information
- Eurecat (Eurecat 2017 Research Projects)
This publication has 65 references indexed in Scilit:
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot studyMedicina Intensiva (English Edition), 2012
- Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromesCritical Care, 2012
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgeryIntensive Care Medicine, 2008
- Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in Gram‐negative sepsisThe FASEB Journal, 2006
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Acute phase response in heifers with experimentally induced mastitisJournal of Dairy Research, 1996
- The Excessive Complement Activation in Fulminant Meningococcal Septicemia Is Predominantly Caused by Alternative Pathway ActivationThe Journal of Infectious Diseases, 1996